ENTO

Entero Therapeutics, Inc. (ENTO)

US
$ 0.50916.48%

Price Chart

Key Statistics

Market Cap
$ 1.79M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
5.63M
52W High
$ 3.16
52W Low
$ 0.18
Dividend Yield
0.00%
Beta
0.89

Technicals

50-Day MA
0.4776
200-Day MA
0.5346
52 Week High
3.16
52 Week Low
0.185

About ENTO

Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for the treatment of patients with gastrointestinal disease.

Employees
2
Headquarters
Boca Raton, FL
CEO
Mr. Richard Joel Paolone

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg